There are 2789 resources available
257P - Health-related quality of life (HRQoL) in the ASCENT study of sacituzumab govitecan (SG) in metastatic triple-negative breast cancer (mTNBC)
Presenter: Sibylle Loibl
Session: ePoster Display
146P - Prognostic impact of HER2-low expression according to the oncotype Dx recurrence score in hormone receptor-positive early breast cancer
Presenter: Raz Mutai
Session: ePoster Display
149P - Can high Ki67 predict distant recurrence in early stage breast cancer with low oncotype Dx score?
Presenter: Parvaneh Fallah
Session: ePoster Display
150P - Dysregulation of immune checkpoint proteins in newly-diagnosed early breast cancer patients
Presenter: Bernardo Rapoport
Session: ePoster Display
98P - A stable NGS method to detect microsatellite instability status across different batches, sequencing platforms and cancer types
Presenter: Chenghong Lin
Session: ePoster Display
153P - Adjuvant endocrine therapy combined with abemaciclib in monarchE patients with high-risk early breast cancer: Disease characteristics and endocrine therapy choice by menopausal status
Presenter: Shani Paluch-Shimon
Session: ePoster Display
274P - Metronomic oral vinorelbine (MOV) combined with tremelimumab (T) + durvalumab (D): Efficacy and safety results of the advanced breast cancer (ABC) patients (pts) cohort of the MOVIE study
Presenter: Thibault De La Motte Rouge
Session: ePoster Display
113P - The analysis of EGFR fusions characteristics in Chinese solid tumor patients
Presenter: Guibing Mao
Session: ePoster Display
161P - Population effectiveness model of the consequences of recurrence after trastuzumab emtansine (T-DM1) treatment among U.S. patients with high-risk HER2+ early-stage breast cancer (ESBC)
Presenter: David Veenstra
Session: ePoster Display